Replies to post #215515 on Biotech Values

[DewDiligence]

Refresher on RVNC phase-2 CD* data that triggered the decision to advance the CD program to phase-3:

#msg-131479120
#msg-131924083


11/29/17 press release (for archival purposes):
http://investors.revance.com/releasedetail.cfm?ReleaseID=1050212

*Cervical dystonia.